Stay updated on Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma
Sign up to get notified when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.

Latest updates to the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the study's purpose, inclusion and exclusion criteria, and details about the treatment for relapsed or refractory Natural Killer/T Cell Lymphoma. Additionally, the principal investigator's name has been deleted.SummaryDifference23%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Salvage Therapies in NK/T Cell Lymphoma page.